H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) shares dropped 49.5% during mid-day trading on Thursday . The stock traded as low as $2.02 and last traded at $2.02. Approximately 400 shares traded hands during trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Trading Down 49.5 %
The company’s fifty day simple moving average is $2.02 and its 200-day simple moving average is $2.02.
About H-CYTE
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than H-CYTE
- Dividend Payout Ratio Calculator
- 5 Best Gold ETFs for March to Curb Recession Fears
- Insider Buying Explained: What Investors Need to Know
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
